A randomised multicentre open-label study evaluating the efficacy and safety of prolonged antiplatelet therapy in patients with coronary disease has found that 24 months' duration of dual therapy is no better than six months ...
Aug 30, 2011
0
0
The European Society of Cardiology (ESC Working Group on Thrombosis) is calling for greater attention to be paid by health care staff to reducing bleeding in patients with acute coronary syndromes (ACS) undergoing percutaneous ...
Jun 30, 2011
0
0
When taken with higher doses of aspirin (more than 300 milligrams), the experimental antiplatelet drug ticagrelor was associated with worse outcomes than the standard drug, clopidogrel, but the opposite was true with lower ...
Jun 27, 2011
0
0
Researchers in Poland have discovered that combining omega-3 fatty acids with two blood-thinning drugs, aspirin and clopidogrel, changed the process of blood clotting, potentially helping reduce the risk of heart attacks ...
Jun 21, 2011
0
0
Robert Storey, Professor of Cardiology at the University of Sheffield's Department of Cardiovascular Science, presented findings today that confirm one in five deaths in the year following a heart attack could be prevented ...
Jun 13, 2011
0
0
Results of a study, involving 98,454 patients demonstrated that at 30 days following their first heart attack, RA patients were approximately 20% less likely to be prescribed standard MI treatments, such as statins and betablockers, ...
May 27, 2011
0
0
Omega-3 fatty acids, combined with two blood-thinning drugs, significantly changed the blood-clotting process and may reduce the risk of heart attacks in patients with stents in their heart arteries, according to research ...
May 26, 2011
0
1
